Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2026-05-15 @ 12:52 PM
Study NCT ID:
NCT06860594
Status:
RECRUITING
Last Update Posted:
2025-12-24
First Post:
2025-03-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Astrocytoma, IDH-Mutant, Grade 2 | View |
| None | Recurrent Adult Diffuse Hemispheric Glioma, H3 G34-Mutant | View |
| None | Recurrent Adult Diffuse Midline Glioma, H3 K27-Mutant | View |
| None | Recurrent Astrocytoma, IDH-Mutant | View |
| None | Recurrent Astrocytoma, IDH-Mutant, Grade 3 | View |
| None | Recurrent Astrocytoma, IDH-Mutant, Grade 4 | View |
| None | Recurrent Glioblastoma, IDH-Wildtype | View |
Keywords: